Side effects of chemotherapy in musculoskeletal oncology

Journal of Long-Term Effects of Medical Implants

Volumn 20, Issue 1, 2010, Pages 1-12

  Mavrogenis, Andreas F ^a   Papagelopoulos, Panayiotis J ^b   Romantini, Matteo ^a   Angelini, Andrea ^a   Ruggieri, Pietro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Chemotherapy; Complications

Indexed keywords

BONE; DISEASE CONTROL; DRUG INTERACTIONS; ENZYME INHIBITION; MULTI AGENT SYSTEMS; ONCOLOGY; PATIENT TREATMENT; TISSUE; TUMORS;

ADVERSE EFFECT; ANTI-PROLIFERATIVE; ANTINEOPLASTIC AGENTS; COMPLICATIONS; FRACTURE HEALING; MULTIPLE AGENTS; OVERALL SURVIVAL; SOFT TISSUE TUMOR;

CHEMOTHERAPY;

ALKYLATING AGENT; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; BLEOMYCIN; BUSULFAN; CARMUSTINE; CHLORMETHINE; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; MITOMYCIN; NITROSOUREA DERIVATIVE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; THIOTEPA; TIOGUANINE; VINCRISTINE; WARFARIN;

ACUTE LEUKEMIA; ADULT; ASEPTIC MENINGITIS; BLOOD VESSEL INJURY; BONE; BONE ALLOGRAFT; BONE GRAFT; BONE METABOLISM; BONE PAIN; BONE TUMOR; BONE TURNOVER; BRACHIAL PLEXUS INJURY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CHILD; CHILDHOOD LEUKEMIA; COGNITIVE DEFECT; DISEASE FREE SURVIVAL; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG FORMULATION; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; FRACTURE; FRACTURE HEALING; GROWTH DISORDER; HEADACHE; HUMAN; INAPPROPRIATE VASOPRESSIN SECRETION; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TOXICITY; LYMPHOMA; MUCOSA INFLAMMATION; MUSCULOSKELETAL SYSTEM; NEPHROBLASTOMA; NEPHROTOXICITY; NEUROLYSIS; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; OSTEOPOROSIS; OSTEOTOMY; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PERIPHERAL NERVE INJURY; RADIATION DOSE; RADIATION INJURY; REVIEW; RHABDOMYOSARCOMA; SEIZURE; SINGLE DRUG DOSE; SOFT TISSUE SARCOMA; SOFT TISSUE TUMOR; SOLID TUMOR; SPINAL CORD DISEASE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; TUMOR; WOUND HEALING; WOUND HEALING IMPAIRMENT;

EID: 79551588956     PISSN: 10506934     EISSN: None     Source Type: Journal    
DOI: 10.1615/JLongTermEffMedImplants.v20.i1.10     Document Type: Review

References (109)

1. Chan KW, Knowling M, Beauchamp CP. Perioperative chemotherapy for primary sarcoma of bone. Can J Surg. 1989;32:43-6. (Pubitemid 19045174)
2. Jaffe N, Frei E III, Watts H, Traggis D. High-dose methotrexate in osteogenic sarcoma: A 5-year experience. Cancer Treat Rep. 1978;62:259-64. (Pubitemid 8287340)
3. Sutow WW, Gehan EA, Dyment PG, Vietti T, Miale T. Multidrug adjuvant chemotherapy for osteosarcoma: interim report of the southwest oncology group studies. Cancer Treat Rep. 1978;62:265-9.
4. Cannon CP, Ballo MT, Zagars GK, Mirza AN, Lin PP, Lewis VO, Yasko AW, Benjamin RS, Pisters PWT. Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas. Cancer. 2006;107:2455-61.
5. Ozger H, Bulbul M, Eralp L. Complications of limb salvage surgery in childhood tumors and recommended solutions. Strat Traum Limb Recon. 2010;5:11-5.
6. Hundsdoerfer P, Albrecht M, Rühl U, Fengler R, Kulozik AE, Henze G. Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma. Eur J Cancer. 2009;45:2447-51.
7. Soussain C, Ricard D, Fike JR, Mazeron JJ, Psimaras D, Delattre J-Y. CNS complications of radiotherapy and chemotherapy. Lancet. 2009;374:1639-51.
8. Hopewell JW, Trott KR. Volume effects in radiobiology as applied to radiotherapy. Radiother Oncol. 2000;56:283-8.
9. Aisner J, Morris D, Elias EG, Wiernik PH. Mastectomy as an adjuvant to chemotherapy for locally advanced or metastatic breast cancer. Arch Surg. 1982;117:882-7. (Pubitemid 12080904)
10. Bertermann O, Marcove RC, Rosen G. Effect of intensive adjuvant chemotherapy on wound healing in 69 patients with osteogenic sarcomas of the lower extremities. Recent Results Cancer Res. 1985;98:135-41.
11. Enneking WF, Eady JL, Burchard H. Autogenous cortical bone grafts in reconstruction of segmental skeletal defects. J Bone Joint Surg Am. 1980;62:1039-58.
12. Graves G, Gaaf JH. Effects of chemotherapy on the healing of surgical wounds. Clin Bull Memorial Sloane Kettering Cancer Centre. 1980;10:4.
13. McDonald DJ, Capanna R, Gherlinzoni F, Bacci G, Ferruzzi A, Casadei R, Ferraro A, Cazzola A, Campanacci M. Influence of chemotherapy on perioperative complications in limb salvage for bone tumors. Cancer. 1990;65:1509-16.
14. Shamberger RC, Devereux DF, Brennan MF. The effect of chemotherapeutic agents on wound healing. Int Adv Surg Oncol. 1981;4:15-81.
15. Cohen SC, Gabelnick HL, Johnson RK, Goldin A. Effects of antineoplastic agents on wound healing in mice. Surgery. 1975;78:238-44.
16. Cohen SC, Gabelnick HL, Johnson RK, Goldin A. Effects of cyclophosphamide and adriamycin on the healing of surgical wounds in mice. Cancer. 1975;36:1277-81.
17. Devereux DF, Thibault L, Boretos J, Brennan MF. The quantitative and qualitative impairment of wound healing by adriamycin. Cancer. 1979;43:932-8. (Pubitemid 9163622)
18. Lawrence WT, Norton JA, Harvey AK, Gorschboth CM, Talbot TL, Grotendorst GR. Doxorubicin-induced impairment of wound healing in rats. J Nat Cancer Inst. 1986;76:119-26.
19. Lawrence WT, Talbot TL, Norton JA. Preoperative or postoperative doxorubicin hydrochloride (adriamycin): which is better for wound healing? Surgery. 1986;100:9-13.
20. Khoo DBA. The effect of chemotherapy on soft tissue and bone healing in the rabbit model. Ann Acad Med. 1992;21:217-21.
21. Mitchell MJ, Logan MP. Radiation-induced changes in bone. Radiographics. 1998;18:1125-36.
22. Krasin MJ, Xiong X, Wu S, Merchant TE. The effects of external beam irradiation on the growth of flat bones in children: Modeling a dose-volume effect. Int J Radiat Biol Phys. 2005;62:1458-63.
23. Edeiken BS, Libshitz HI, Cohen MA. Slipped proximal humeral epiphysis: a complication of radiotherapy to the shoulder in children. Skeletal Radiol. 1982;9:123-5.
24. Libshitz HI, Edeiken BS. Radiotherapy changes of the pediatric hip. AJR Am J Roentgenol. 1981;137:585-8.
25. Dalinka MK, Mazzeo VP. Complications of radiation therapy. Cmit Rev Diagn Imaging. 1985;23:235-67.
26. Dawson WB. Growth impairment following radiotherapy in childhood. Clin Radiol. 1968;19:241-56.
27. Alho A, Karaharju EO, Korkala O, Laasonen EM, Holmström T, Müller C. Allogeneic grafts for bone tumor: 21 cases of osteoarticular and segmental grafts. Acta Orthop Scand. 1989;60:143-53.
28. Prosnitz LR, Lawson JP, Friedlaender GE, Farber LR, Pezzimenti JF. Avascular necrosis of bone in Hodgkin's disease patients treated with combined modality therapy. Cancer. 1981;47:2793-7.
29. Ragab AH, Frech RS, Vietti TJ. Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer. 1970;25:580-5.
30. Robins PR, Jowsey J. Effect of mithramycin on normal and abnormal bone turnover. J Lab and Clin Med. 1973;82:576-86.
31. Stanislavjevic S, Babcock AL. Fractures in children treated with methotrexate for leukemia. Clin Orthop Relat Res. 1977;125:139-44.
32. Friedlaender GE, Tross RB, Doganis AC, Kirkwood JM, Baron R. Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat mode. J Bone Joint Surg Am. 1984;4:602-7.
33. Virolainen P, Inoue N, Nagao M, Frassica FJ, Chao EY. The effect of a doxorubicin, cisplatin and ifosfamide combination chemotherapy on bone turnover. Anticancer Res. 2002;22:1971-5.
34. Blomlie V, Rofstad EK, Talle K, Sundfør K, Winderen M, Lien HH. Incidence of radiation-induced insufficiency fractures of the female pelvis: evaluation with MR imaging. AJR Am J Roentgenol. 1996;167(5):1205-10.
35. Shapeero LG, De Visschere PJL, Verstraete KL, Poffyn B, Forsyth R, Sys G, Uyttendaele D. Post-treatment complications of soft tissue tumours. Eur J Radiol. 2009;69:209-221.
36. Gortzak Y, Lockwood GA, Mahendra A, Wang Y, Chung PWM, Catton CN, O'Sullivan B, Deheshi BM, Wunder JS, Ferguson PC. Prediction of pathologic fracture risk of the femur after combined modality treatment of soft tissue sarcoma of the thigh. Cancer. 2010;116:1553-9.
37. Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz M, Bodurka DC, Sood AK. Pelvic fractures after radiotherapy for cervical cancer. Implications for survivors. Cancer. 2010;116:625-30.
38. Jenkins PJ, Montefiore DJ, Arnott SJ. Hip complications following chemoradiotherapy. Clin Oncol (R Coll Radiol). 1995;7:123-6.
39. Helmstedter CS, Goebel M, Zlotecki R, Scarborough MT. Pathologic fractures after surgery and radiation for soft tissue tumors. Clin Orthop Relat Res. 2001;389:165-72.
40. Holt GE, Griffin AM, Pintilie M, Wunder JS, Catton C, O'Sullivan B, Bell RS. Fractures following radiotherapy and limb-salvage surgery for lower extremity soft-tissue sarcomas: A comparison of high-dose and low-dose radiotherapy. J Bone Joint Surg Am. 2005;87:315-9.
41. Lin PP, Schupak KD, Boland PJ, Brennan MF, Healey JH. Pathologic femoral fracture after periosteal excision and radiation for the treatment of soft tissue sarcoma. Cancer. 1998;82:2356-65.
42. Baxter NN, Habermann EB, Tepper JE, Durham SB, Virnig BA. Risk of pelvic fractures in older women following pelvic irradiation. JAMA. 2005;294:2587-93.
43. Grangier C, Garcia J, Howarth NR, May M, Rossier P. Role of MRI in the diagnosis of insufficiency fractures of the sacrum and acetabular roof. Skeletal Radiol. 1997;26:517-24. (Pubitemid 27445532)
44. O'Sullivan B, Davis A, Turcotte R, Bell R, Catton C, Chabot P, Wunder J, Kandel R, Goddard K, Sadura A, Pater J, Zee B. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359:2235-41.
45. Lin PP, Boland PJ, Healey JH. Treatment of femoral fractures after irradiation. Clin Orthop Relat Res. 1998;352:168-78.
46. Burchardt H, Glowczewskie, FP Jr, Enneking WF. The effect of adriamycin and methotrexate on the repair of segmental cortical autografts in dogs. J Bone Joint Surg Am. 1983;65:103-8.
47. Friedlaender GE, Goodman A, Hausman M, Troiano N. The effects of methotrexate and radiation therapy on histologic aspects of fracture healing. Trans Orthop Res Soc. 1983;8:224.
48. Hajj A, Mnaynmeh W, Ghandur-Mnaymneh L, Latta L. The effects of methotrexate on the healing of rats femora. Trans Orthop Res Soc. 1981;6:79.
49. Young DR, Shih LY, Rock MG, Frassica FJ, Virolainen P, Chao EY. Effect of cisplatin chemotherapy on extracortical tissue formation in canine diaphyseal segmental replacement. J Orthop Res. 1997;15:773-80.
50. Penttinen R. Biochemical studies on fracture healing rat. Acta Chir Scand. 1972;432:1-32.
51. Nilsonne U. The distribution of mineral salts in nonunion of fractures. Acta Orthop Scand. 1961;31:81-9.
52. Hansen TM, Prause JU, Lorenzen I. Effect of different cyclophosphamide treatment schedules on collagen and collagenolytic activity in granulation tissue. Acta Pharmacol Toxicol. 1978;42:219-25.
53. Udupa KN, Prasad GC. Chemical and histochemical studies on the organic constituents in fracture repair in rats. J Bone Joint Surg Br. 1963;45:770-9.
54. Sanyal AK, Singh S. Abnormal patterns of ossifi cation in foot bones of rat fetuses induced cyclophosphamide. Anal Anz. 1974;136:1-9.
55. Sommer-Tsilenis EH, Saner HD, Kruse HP. Delaying effect of cyclophospamide on bone fracture healing. Chemical analyses of rat femora. Arch Orthop Trauma Surg. 1983;101:89-93.
56. Morcuende JA, Gomez P, Stack J, Oji G, Martin J, Fredericks DC, Buckwalter JA. Effect of chemotherapy on segmental bone healing enhanced by rhBMP-2. Iowa Orthop J. 2004;24:36-42.
57. Virolainen P, Inoue N, Nagao M, Frassica FJ, Chao EY. The effect of multidrug chemotherapy on bone graft augmented prosthesis fixation. J Orthop Res. 2005;23:795-801.
58. Delloye C, de Nayer P, Allington N, Munting E, Coutelier L, Vincent A. Massive bone allografts in large skeletal defects after tumor surgery: a clinical and microradiographic evalution. Arch Orthop Trauma Surg. 1988;107:31-41.
59. Ortiz-Cruz E, Gebhardt MC, Jennings LC, Springfield DS, Mankin HJ. The results of transplantation of intercalary allografts after resection of tumors. A long-term follow up study. J Bone Joint Surg Am. 1997;79:97-106.
60. Shinohara N, Yokoyama K, Chuman H. Massive bone allografts in large bone defects after tumor surgery: A clinical long-term study. Gan To Kagaku Ryoho. 1989;16:1820-6.
61. Stevenson S, Fredericks RW, Zart DJ, Li XQ, Bensusan J, Davy D, Klein L, Goldberg VM. The interaction and effects of freezing and histocompatibility on the incorporation of allogeneic cortical grafts in rats. Trans Orthop Res Soc. 1989;14:269.
62. Stevenson S, Fredericks RW, Li XQ, Zart DJ, Bensusan J, Davy D, Klein L, Goldberg VM. Together, the host bed and the properties of the graft determine the outcome of graft incorporation. Trans Orthop Res Soc. 1989;14:463.
63. Zart DJ, Miya L, Wolff DA, Makley JT, Stevenson S. The effects of cisplatin on the incorporation of fresh syngeneic and frozen allogeneic cortical bone grafts. J Orthop Res. 1993;11:240-9. (Pubitemid 23159351)
64. Bernstein M, Kovar H, Paulussen M. Ewing's sarcoma family of tumors: current management. Oncologist. 2006;11:503-19.
65. Verstappen C, Heimans J, Hoekman K, Postma T. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs. 2003;63:1549-63.
66. Dietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol. 2006;5:22.
67. Sugimoto S, Yamamoto YL, Nagahiro S, Diksic M. Permeability change and brain tissue damage after intracarotid administration of cisplatin studied by double-tracer autoradiography in rats. J Neurooncol. 1995;24:229-40.
68. Eberly AL, Anderson GD, Bubalo JS, McCune JS. Optimal prevention of seizures induced by high-dose busulfan. Pharmacotherapy. 2008;28:1502-10.
69. Patel PN. Methylene blue for management of ifosfamide-induced encephalopathy. Ann Pharmacother. 2006;40:299-303.
70. Hunault-Berger M, Chevallier P, Delain M, Bulabois CE, Bologna S, Bernard M, Lafon I, Cornillon J, Maakaroun A, Tizon A, Padrazzi B, Ifrah N, Gruel Y; GOELAMS (Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang). Changes in antithrombin and fibrinogen levels during induction chemotherapy with l-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the capelal study. Haematologica. 2008;93:1488-94.
71. Zakarija A, Bennett C. Drug-induced thrombotic microangiopathy. Semin Thromb Hemost. 2005;31:681-90.
72. Kamba T, McDonald DM. Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br J Cancer. 2007;96:1788-95.
73. Moore-Maxwell CA, Datto MB, Hulette CM. Chemotherapy-induced toxic leukoencephalopathy causes a wide range of symptoms: a series of four autopsies. Mod Pathol. 2004;17:241-7.
74. Rajasekhar A, George TJJ. Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature. Oncologist. 2007;12:1332-35.
75. Martin G, Bellido L, Cruz JJ. Reversible posterior leukoencephalopathy syndrome induced by sunitinib. J Clin Oncol. 2007;25:3559.
76. Kastrup O, Diener HC. TNF-antagonist etanercept induced reversible posterior leukoencephalopathy syndrome. J Neurol. 2008;255:452-53.
77. Onujiogu N, Lengyel E, Yamada SD. Reversible posterior leukoencephalopathy syndrome following intravenous paclitaxel and intraperitoneal cisplatin chemotherapy for fallopian tube cancer. Gynecol Oncol. 2008;111:537-39.
78. Graus F. Acute meningospinal syndromes: acute myelopathy and radiculopathy. In: Hildebrandt J, editor. Neurological adverse reactions to anticancer drugs. Berlin: Springer; 1990. p. 87-92.
79. Perry A, Schmidt RE. Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol. 2006;111:197-212.
80. Troy L, McFarland K, Littman-Power S, Kelly BJ, Walpole ET, Wyld D, Thomson D. Cisplatin-based therapy: a neurological and neuropsychological review. Psychooncology. 2000;9:29-39.
81. Sierra del Rio M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K. Primary CNS lymphoma in immunocompetent patients. Oncologist. 2009;14: 526-39.
82. Dropcho EJ. Neurotoxicity of Radiation Therapy. Neurol Clin. 2010;28:217-34.
83. Sheline G. Radiation therapy of brain tumors. Cancer. 1977;39:873-81.
84. Correa DD, DeAngelis LM, Shi W, Thaler H, Glass A, Abrey LE. Cognitive functions in survivors of primary central nervous system lymphoma. Neurology. 2004;62:548-55.
85. Brandes AA, Tosoni A, Spagnolli F, Frezza G, Leonardi M, Calbucci F, Franceschi E. Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology. Neuro Oncol. 2008;10: 361-7.
86. Seddon BM, Cassoni AM, Galloway MJ, Rees JH, Whelan JS. Fatal radiation myelopathy after high-dose busulfan and melphalan chemotherapy and radiotherapy for Ewing's sarcoma. Clin Oncol (R Coll Radiol). 2005 Aug;17(5):385-90.
87. Gatcombe H, Lawson J, Phuphanich S, Crocker I. Treatment related myelitis in Hodgkin's lymphoma following stem cell transplant, chemotherapy and radiation. J Neurooncol. 2006;79:293-8.
88. Merimsky O, Soyfer V, Kovner F, Bickels J, Issakov J, Flusser G, Meller I, Ofer O, Kollender Y. Limb sparing approach: adjuvant radiation therapy in adults with intermediate or high-grade limb soft tissue sarcoma. Radiother Oncol. 2005;77:295-300.
89. Livi L, Antoni R, Paiar F, Bastiani P, Beltrami G, Caldora P, Capanna R, De Biase P, Detti B, Fondelli S, Meldolesi E, Pertici M, Polli C, Simontacchi G, Biti G. Late treatment-related complications in 214 patients with extremity soft-tissue sarcoma treated by surgery and postoperative radiation therapy. Am J Surg. 2006;191:230-4.
90. Olsen NK, Pfeiffer P, Johannsen L, Schrøder H, Rose C. Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients. Int J Radiat Oncol Biol Phys. 1993;26:43-9.
91. Harper CM, Thomas JE, Cascino TL, Litchy WJ. Distinction between neoplastic and radiation-induced brachial plexopathy, with emphasis on the role of EMG. Neurology. 1989;39:502-6.
92. Thyagarajan D, Cascino T, Harms G. Magnetic resonance imaging in brachial plexopathy of cancer. Neurology. 1995;45:421-7.
93. Teixeira MJ, Fonoff ET, Montenegro MC. Dorsal root entry zone lesions for treatment of pain related to radiation-induced plexopathy. Spine. 2007;32:E316-9.
94. Fathers E, Thrush D, Huson SM, Norman A. Radiation-induced brachial plexopathy in women treated for carcinoma of the breast. Clin Rehabil. 2002;16:160-5.
95. Dubuisson AS, Kline DG, Weinshel SS. Posterior subscapular approach to the brachial plexus: report of 102 patients. J Neurosurg. 1993;79:319-30.
96. Floyd J, Mirza I, Sachs B, Perry MC. Hepatotoxicity of chemotherapy. Semin Oncol. 2006;33:50-67.
97. Rodriguez-Frias EA, Lee WM. Cancer chemotherapy II: Atypical hepatic injuries. Clin Liver Dis. 2007;11:663-76, viii.
98. Castellino S, Muir A, Shah A, Shope S, McMullen K, Ruble K, Barber A, Davidoff A, Hudson MM. Hepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2010;54:663-9.
99. Socie G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, Cahn JY, Passweg JR, Rowlings PA, Schouten HC, Kolb HJ, Klein JP. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med. 1999;341:14-21.
100. Piel B, Vaidya S, Lancaster D, Taj M, Pritchard-Jones K. Chronic hepatotoxicity following 6-thioguanine therapy for childhood acute lymphoblastic leukaemia. Br J Haematol. 2004;125:410-2.
101. Sulis ML, Bessmertny O, Granowetter L, Weiner M, Kelly KM. Veno-occlusive disease in pediatric patients receiving actinomycin D and vincristine only for the treatment of rhabdomyosarcoma. J Pediatr Hematol Oncol. 2004;26:843-6.
102. Greten TF, Manns MP, Reinisch I, Kaatsch P. Hepatocellular carcinoma occurring after successful treatment of childhood cancer with high dose chemotherapy and radiation. Gut. 2005;54:732.
103. Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, Ronckers CM, Friedman DL, Stovall M, Yasui YY, Robison LL, Meadows AT, Kadan-Lottick NS. Risk of selected subsequent carcinomas in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24:476-83.
104. Lennard L, Richards S, Cartwright CS, Mitchell C, Lilleyman JS, Vora A; UK MRC/NCRI Childhood Leukaemia Working Party. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia. Clin Pharmacol Ther. 2006;80:375-83.
105. Broxson EH, Dole M,Wong R, Laya BF, Stork L. Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy. Pediatr Blood Cancer. 2005;44:226-31.
106. De Bruyne R, Portmann B, Samyn M, Bansal S, Knisely A, Mieli-Vergani G, Dhawan A. Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia. J Hepatol. 2006;44:407-10.
107. Hutter RV, Shipkey FH, Tan CT, Murphy ML, Chowdhury M. Hepatic fibrosis in children with acute leukemia: A complication of therapy. Cancer. 1960;13:288-307.
108. Parker D, Bate CM, Craft AW, Graham-Pole J, Malpas JS, Stansfeld AG. Liver damage in children with acute leukaemia and non-Hodgkin's lymphoma on oral maintenance chemotherapy. Cancer Chemother Pharmacol. 1980;4:121-7.
109. Greve J, Bas M, Schuler P, Turowski B, Scheckenbach K, Budach W, Bölke E, Bergmann C, Lang S, Arweiler-Harbeck D, Lehnerdt G, Mattheis S, Bier H, Hoffmann TK. Acute arterial hemorrhage following radiotherapy of oropharyngeal squamous cell carcinoma. Strahlenther Onkol. 2010;186(5): 269-73.